Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
May 27, 2016 $16.52 $16.52 $16.52 $16.52 38 491
May 26, 2016 $16.10 $16.10 $16.10 $16.10 20 307
May 25, 2016 $16.28 $16.28 $16.28 $16.28 63 749
May 24, 2016 $16.29 $16.29 $16.29 $16.29 76 388
May 23, 2016 $15.97 $15.97 $15.97 $15.97 109 705
May 20, 2016 $15.58 $15.58 $15.58 $15.58 38 322
May 19, 2016 $15.12 $15.12 $15.12 $15.12 56 737
May 18, 2016 $15.67 $15.67 $15.67 $15.67 131 927
May 17, 2016 $14.66 $14.66 $14.66 $14.66 100 207
May 16, 2016 $15.02 $15.02 $15.02 $15.02 78 621
May 13, 2016 $14.64 $14.64 $14.64 $14.64 177 191
May 12, 2016 $13.72 $13.72 $13.72 $13.72 118 311
May 11, 2016 $13.81 $13.81 $13.81 $13.81 113 460
May 10, 2016 $14.05 $14.05 $14.05 $14.05 187 762
May 09, 2016 $14.20 $14.20 $14.20 $14.20 180 370
May 06, 2016 $14.26 $14.26 $14.26 $14.26 151 758
May 05, 2016 $14.42 $14.42 $14.42 $14.42 148 155
May 04, 2016 $14.69 $14.69 $14.69 $14.69 90 149
May 03, 2016 $14.97 $14.97 $14.97 $14.97 67 134
May 02, 2016 $15.55 $15.55 $15.55 $15.55 135 444
Apr 29, 2016 $15.71 $15.71 $15.71 $15.71 65 345
Apr 28, 2016 $16.19 $16.19 $16.19 $16.19 228 376
Apr 27, 2016 $16.09 $16.09 $16.09 $16.09 108 154
Apr 26, 2016 $16.81 $16.81 $16.81 $16.81 86 111
Apr 25, 2016 $17.44 $17.44 $17.44 $17.44 119 705
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT